ArticleDiabetes, obesity & metabolism2026

A Biweekly GLP-1R Agonist Designed With Drug-Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability.

Wei Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.